- Home
- GCO vs LRMR Comparison
GCO vs LRMR Comparison
Compare GCO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCO | LRMR |
|---|---|---|
| Founded | 1924 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.0M | 280.0M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GCO | LRMR |
|---|---|---|
| Price | $26.84 | $5.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $31.33 | $16.29 |
| AVG Volume (30 Days) | 209.2K | ★ 6.6M |
| Earning Date | 06-05-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,606,898,000.00 | N/A |
| Revenue This Year | $5.42 | N/A |
| Revenue Next Year | $1.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.71 | N/A |
| 52 Week Low | $16.19 | $1.61 |
| 52 Week High | $38.95 | $6.42 |
Technical Indicators
Market Signals| Indicator | GCO | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 63.93 |
| Support Level | $25.65 | $3.18 |
| Resistance Level | $29.79 | $6.42 |
| Average True Range (ATR) | 1.79 | 0.58 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 35.90 | 76.25 |
Price Performance
Historical ComparisonAbout GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.